Annual Working Capital
$76.75 M
-$32.42 M-29.69%
December 31, 2023
Summary
- As of February 7, 2025, MCRB annual working capital is $76.75 million, with the most recent change of -$32.42 million (-29.69%) on December 31, 2023.
- During the last 3 years, MCRB annual working capital has fallen by -$145.61 million (-65.48%).
- MCRB annual working capital is now -65.48% below its all-time high of $222.36 million, reached on December 31, 2020.
Performance
MCRB Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$8.10 M
-$32.89 M-80.25%
September 30, 2024
Summary
- As of February 7, 2025, MCRB quarterly working capital is $8.10 million, with the most recent change of -$32.89 million (-80.25%) on September 30, 2024.
- Over the past year, MCRB quarterly working capital has dropped by -$68.66 million (-89.45%).
- MCRB quarterly working capital is now -97.13% below its all-time high of $282.02 million, reached on March 31, 2016.
Performance
MCRB Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
MCRB Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.7% | -89.5% |
| 3 y3 years | -65.5% | -92.6% |
| 5 y5 years | +51.6% | -92.6% |
MCRB Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.3% | at low | -96.3% | at low |
| 5 y | 5-year | -65.5% | +41.6% | -96.9% | at low |
| alltime | all time | -65.5% | >+9999.0% | -97.1% | at low |
Seres Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.10 M(-80.2%) |
| Jun 2024 | - | $40.98 M(-38.6%) |
| Mar 2024 | - | $66.70 M(-13.1%) |
| Dec 2023 | $76.75 M(-29.7%) | $76.75 M(-43.2%) |
| Sep 2023 | - | $135.17 M(-22.0%) |
| Jun 2023 | - | $173.34 M(+231.7%) |
| Mar 2023 | - | $52.26 M(-52.1%) |
| Dec 2022 | $109.17 M(-50.7%) | $109.17 M(-34.1%) |
| Sep 2022 | - | $165.69 M(+37.5%) |
| Jun 2022 | - | $120.54 M(-33.4%) |
| Mar 2022 | - | $180.89 M(-18.3%) |
| Dec 2021 | $221.37 M(-0.4%) | $221.37 M(-16.2%) |
| Sep 2021 | - | $264.22 M(+56.9%) |
| Jun 2021 | - | $168.39 M(-17.5%) |
| Mar 2021 | - | $204.12 M(-8.2%) |
| Dec 2020 | $222.36 M(+310.3%) | $222.36 M(-15.2%) |
| Sep 2020 | - | $262.24 M(+821.2%) |
| Jun 2020 | - | $28.47 M(-21.9%) |
| Mar 2020 | - | $36.45 M(-32.7%) |
| Dec 2019 | $54.20 M | $54.20 M(+14.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $47.34 M(-28.2%) |
| Jun 2019 | - | $65.92 M(+151.7%) |
| Mar 2019 | - | $26.19 M(-48.3%) |
| Dec 2018 | $50.62 M(-59.0%) | $50.62 M(+25.2%) |
| Sep 2018 | - | $40.44 M(-37.6%) |
| Jun 2018 | - | $64.77 M(-29.1%) |
| Mar 2018 | - | $91.30 M(-26.0%) |
| Dec 2017 | $123.45 M(-26.5%) | $123.45 M(-17.5%) |
| Sep 2017 | - | $149.61 M(-0.5%) |
| Jun 2017 | - | $150.39 M(-8.9%) |
| Mar 2017 | - | $165.02 M(-1.7%) |
| Dec 2016 | $167.91 M(-14.6%) | $167.91 M(-4.9%) |
| Sep 2016 | - | $176.56 M(-7.0%) |
| Jun 2016 | - | $189.77 M(-32.7%) |
| Mar 2016 | - | $282.02 M(+43.4%) |
| Dec 2015 | $196.69 M(+80.2%) | $196.69 M(-9.6%) |
| Sep 2015 | - | $217.52 M(+146.0%) |
| Jun 2015 | - | $88.42 M(-13.0%) |
| Mar 2015 | - | $101.65 M(-6.9%) |
| Dec 2014 | $109.14 M(>+9900.0%) | $109.14 M |
| Dec 2013 | $649.00 K | - |
FAQ
- What is Seres Therapeutics annual working capital?
- What is the all time high annual working capital for Seres Therapeutics?
- What is Seres Therapeutics annual working capital year-on-year change?
- What is Seres Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Seres Therapeutics?
- What is Seres Therapeutics quarterly working capital year-on-year change?
What is Seres Therapeutics annual working capital?
The current annual working capital of MCRB is $76.75 M
What is the all time high annual working capital for Seres Therapeutics?
Seres Therapeutics all-time high annual working capital is $222.36 M
What is Seres Therapeutics annual working capital year-on-year change?
Over the past year, MCRB annual working capital has changed by -$32.42 M (-29.69%)
What is Seres Therapeutics quarterly working capital?
The current quarterly working capital of MCRB is $8.10 M
What is the all time high quarterly working capital for Seres Therapeutics?
Seres Therapeutics all-time high quarterly working capital is $282.02 M
What is Seres Therapeutics quarterly working capital year-on-year change?
Over the past year, MCRB quarterly working capital has changed by -$68.66 M (-89.45%)